Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth.
Genetic Variation, Magnesium Sulfate Exposure, and Adverse Neurodevelopmental Outcomes Following Preterm Birth.
复制标题
DOI:
10.1055/s-0038-1635109
复制
发表时间:
2018-08
影响因子:
2
通讯作者:
Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units (MFMU) Network
中科院分区:
文献类型:
--
作者:
Clark EAS;Weiner SJ;Rouse DJ;Mercer BM;Reddy UM;Iams JD;Wapner RJ;Sorokin Y;Malone FD;O'Sullivan MJ;Peaceman AM;Hankins GDV;Dudley DJ;Caritis SN;Eunice Kennedy Shriver National Institute of Child Health Human Development Maternal-Fetal Medicine Units (MFMU) Network
To evaluate the association of magnesium sulfate (MgSO4) exposure and candidate gene polymorphisms with adverse neurodevelopmental outcomes following preterm birth. We performed a nested case-control analysis of a randomized trial of maternal MgSO4 before anticipated preterm birth for prevention of cerebral palsy (CP). Cases were children who died by 1 year of life or were survivors with abnormal neurodevelopment at age 2 years. Controls were race- and sex-matched survivors with normal neurodevelopment. We analyzed 45 candidate gene polymorphisms in inflammation, coagulation and vascular regulation pathways and their association with 1) psychomotor delay, 2) mental delay, 3) CP and 4) combined outcome of death/CP. Logistic regression analyses, conditional on maternal race and child sex, and adjusted for treatment group, gestational age at birth and maternal education, were performed. Four hundred and six subjects, 211 cases and 195 controls, were analyzed. Psychomotor delay: The strongest association was for IL6R (rs 4601580) in which each additional copy of the minor allele was associated with an increased risk of psychomotor delay (aOR 3.3; 95%CI 1.7-6.5). Mental delay: Three SNPs in IL6R were associated with mental developmental delay. Additional SNPs in IL6, MBL2, and F7 showed MgSO4 treatment interaction. CP: TLR4 (rs4986790) was associated with CP (aOR 5.5; 95%CI, 1.1-26.9). SNPs in IL1β and PAI1 showed MgSO4 treatment interaction. Death/CP: SNPs in F7 and NOS3 were associated with the combined outcome of death/CP. Candidate gene polymorphisms are associated with death and adverse neurodevelopmental outcomes following preterm birth. MgSO4 may abrogate this genotype association for some loci. Candidate gene polymorphisms are associated with death and adverse neurodevelopmental outcomes in children born preterm; MgSO4 may abrogate this association for some genetic loci.
登录
查看更多内容
影响因子:
37.8
作者:
Orsini F;Villa P;Parrella S;Zangari R;Zanier ER;Gesuete R;Stravalaci M;Fumagalli S;Ottria R;Reina JJ;Paladini A;Micotti E;Ribeiro-Viana R;Rojo J;Pavlov VI;Stahl GL;Bernardi A;Gobbi M;De Simoni MG
通讯作者:
De Simoni MG
影响因子:
3.8
作者:
Li, J;Ji, L
通讯作者:
Ji, L
影响因子:
120.7
作者:
Crowther, CA;Hiller, JE;Haslam, RR
通讯作者:
Haslam, RR
影响因子:
8
作者:
Gibson, Catherine S.;MacLennan, Alastair H.;Nelson, Karin B.
通讯作者:
Nelson, Karin B.
影响因子:
3
作者:
Marret, Stephane;Doyle, Lex W.;Middleton, Philippa
通讯作者:
Middleton, Philippa